IL6 and pancreatic ductal adenocarcinoma: IL-6-induced STAT3 phosphorylation in pancreatic ductal adenocarcinoma (PDAC) was suppressed by blocking IL-6R leading to the attenuation of STAT3 activation in TME toward enhanced sensitivity of cancer cells to chemotherapy (Long et al., 2017).